[Exploring the mechanism of rhizoma coptidis in treating type II diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry]
- PMID: 22667084
- DOI: 10.3724/sp.j.1123.2011.08039
[Exploring the mechanism of rhizoma coptidis in treating type II diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry]
Abstract
Metabolomics was used to explore the mechanism of Rhizoma coptidis in treating type II diabetes mellitus. The rat model of type II diabetes mellitus was constructed by an injection of streptozocin (40 mg/kg), along with diets of fat emulsion. The rats were divided into four groups, the control group, the model group, the Rhizoma coptidis group (10 g/kg) and the metformin group (0.08 g/kg). After the treatment for 30 d, blood samples were collected to test biomedical indexes, and 24 h urine samples were collected for the metabolomics experiment. In the Rhizoma coptidis group, fasting blood glucose (FBG), total cholesterol (TC) and total plasma triglycerides (TG) were significantly decreased by 59.26%, 58.66% and 42.18%, respectively, compared with those in the model group. Based on gas chromatography-mass spectrometry, a urinary metabolomics method was used to study the mechanism of Rhizoma coptidis in treating diabetes mellitus. Based on the principal component analysis, it was found that the model group and control group were separated into two different clusters. The Rhizoma coptidis group was located between the model group and the control group, closer to the control group. Twelve significantly changed metabolites of diabetes mellitus were detected and identified, including 4-methyl phenol, benzoic acid, aminomalonic acid, and so on. After diabetic rats were administered with Rhizoma coptidis, 7 metabolites were significantly changed, and L-ascorbic acid and aminomalonic acid which related with the oxidative stress were significantly regulated to normal. The pharmacological results showed that Rhizoma coptidis could display anti-hyperglycemic and anti-hyperlipidemic effects. The Rhizoma coptidis had antioxidation function in preventing the occurrence of complications with diabetes mellitus to some extent. The work illustrates that the metabolomics method is a useful tool to study the treatment mechanism of traditional Chinese medicine.
Similar articles
-
GC/MS-based metabolomics strategy to analyze the effect of exercise intervention in diabetic rats.Endocr Connect. 2019 Jun;8(6):654-660. doi: 10.1530/EC-19-0012. Endocr Connect. 2019. PMID: 31042671 Free PMC article.
-
[Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].Zhongguo Zhong Yao Za Zhi. 2011 Aug;36(16):2271-6. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22097345 Chinese.
-
[Study on mechanism of combined administration of Coptidis Rhizoma and Rehmanniae Radix in treating type II diabetes mellitus].Zhongguo Zhong Yao Za Zhi. 2014 Feb;39(3):526-30. Zhongguo Zhong Yao Za Zhi. 2014. PMID: 24946561 Chinese.
-
Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review.Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545. Curr Vasc Pharmacol. 2020. PMID: 31291876 Review.
-
[Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms].Zhongguo Zhong Yao Za Zhi. 2015 May;40(9):1660-5. Zhongguo Zhong Yao Za Zhi. 2015. PMID: 26323125 Review. Chinese.
Cited by
-
The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research.Biomed Res Int. 2014;2014:798093. doi: 10.1155/2014/798093. Epub 2014 Apr 10. Biomed Res Int. 2014. PMID: 24818152 Free PMC article. Review.
-
UPLC-Q/TOF-MS-Based Serum Metabolomics Reveals Hypoglycemic Effects of Rehmannia glutinosa, Coptis chinensis and Their Combination on High-Fat-Diet-Induced Diabetes in KK-Ay Mice.Int J Mol Sci. 2018 Dec 11;19(12):3984. doi: 10.3390/ijms19123984. Int J Mol Sci. 2018. PMID: 30544908 Free PMC article.
-
Effects of Huanglian-Renshen-Decoction, a Fixed Mixture of Traditional Chinese Medicine, on the Improvement of Glucose Metabolism by Maintenance of Pancreatic β Cell Identity in db/db Mice.Evid Based Complement Alternat Med. 2019 Mar 19;2019:1232913. doi: 10.1155/2019/1232913. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31015847 Free PMC article.
-
Tian-Huang Formula, a Traditional Chinese Medicinal Prescription, Improves Hepatosteatosis and Glucose Intolerance Targeting AKT-SREBP Nexus in Diet-Induced Obese Rats.Evid Based Complement Alternat Med. 2021 Mar 6;2021:6617586. doi: 10.1155/2021/6617586. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33763145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous